SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is capturing market attention following the announcement that its advanced 18A-P process has entered risk production, a critical milestone for the company's foundry turnaround strategy. Community sentiment is largely focused on this execution checkpoint as a test of Intel's long-term manufacturing credibility, while traders actively debate the stock's potential for further gains amidst shifting institutional interest and broader sector momentum.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is facing significant market backlash and share price pressure following the announcement of its new high-priced AR smart glasses, with investors expressing deep skepticism over the product's viability and the company's long-term strategy. The community is heavily focused on the CEO's leadership, criticizing the high cost of the hardware and debating whether the firm should pivot, pursue an acquisition, or address underlying operational issues instead of relying on its current hardware-focused trajectory.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is attracting significant investor attention driven by a consistent pattern of insider buying from the CEO, which is fueling community optimism about the company's long-term conviction. Traders are also closely monitoring potential macroeconomic shifts, with many positioning for a potential rally if upcoming interest rate discussions lean dovish, while debates persist over the stock's long-term competitive advantages.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft.The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is driving intense retail and institutional engagement as market participants debate its massive valuation following its IPO and recent strategic AI acquisitions. The community remains sharply divided between bulls focused on the company's long-term dominance in the space and AI sectors, and bears expressing concerns over current cash burn, dilution risks, and speculative overvaluation.

Julong Holding Ltd. engages in the business of investment holding activities. It provides intelligent integrated solutions to public utilities, enterprises, commercial, and multifamily properties. The company was founded by Jia Qi Hu on August 07, 2023 and is headquartered in Beijing, China.

Julong Holding Ltd. - Ordinary Shares - Class A

Julong Holding Ltd. is attracting significant retail attention as traders speculate on a potential short squeeze fueled by an exceptionally low float and heavy insider ownership. The community is actively tracking technical setups and historical price momentum, with many participants drawing parallels to other volatile Chinese small-cap stocks while remaining cautious of regulatory trading halts.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health Inc is capturing market attention as investors weigh its potential to become a dominant player in the emerging peptide and GLP-1 wellness market against concerns regarding regulatory prescribing discipline. The community remains highly active, debating the stock's relative strength and future growth trajectory while frequently highlighting the contrast between the company's aggressive subscription-based expansion and broader market volatility.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

The VanEck Semiconductor ETF is capturing significant investor attention as AI infrastructure demand continues to drive a rally, though concerns over extreme overbought levels and sector concentration are fueling intense debate about a potential bubble. Community members are actively analyzing the sustainability of the semiconductor super-cycle, balancing bullish sentiment regarding data center expansion against warnings of a looming volatility reset.

Investment Managers Series Trust II - Tradr 2X Short SpaceX Daily ETF

Tradr 2X Short SpaceX Daily ETF

Tradr 2X Short SpaceX Daily ETF is generating intense interest as a tool for traders to hedge against or bet against the high valuation of SpaceX. The community is actively debating the timing of potential pullbacks and using the ticker as a high-risk, leveraged alternative to traditional put options.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna shares are oscillating as investors digest positive oncology data from the ASCO conference alongside headlines about a potential Hantavirus outbreak and ongoing FDA reviews for its flu and COVID vaccine candidates. The community is actively debating the company's long-term pivot toward oncology, the potential for a short squeeze, and how upcoming regulatory decisions will impact its future pipeline.

Lionsgate Studios Corp. operates as a standalone, pure-play content company focused on creating, producing, and distributing premium entertainment across multiple formats and platforms. It operates through the following segments: Motion Picture and Television Production. The Motion Picture segment includes the development and production of feature films, acquisition of North American and worldwide distribution rights, North American theatrical, home entertainment, and television distribution of produced and acquired films, as well as the worldwide licensing of distribution rights. The Television Production segment covers the development, production, and worldwide distribution of television content, including series, television movies, mini-series, and non-fiction programming. The company was founded on January 13, 2024 and is headquartered in Vancouver, Canada.

Lionsgate Studios Corp. - Ordinary Shares - New

Lionsgate Studios Corp.

Lionsgate Studios is trending as investors digest news of a potential acquisition by Legendary Entertainment, fueling speculation about a competitive bidding war for the studio's extensive IP library. Community members are actively debating the viability of the buyout, with many highlighting the studio's significant franchise value and recent box office momentum as key drivers for the sudden surge in interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tenax Therapeutics, Inc. (NASDAQ:TENX) Given Consensus Rating of "Moderate Buy" by Brokerages

Shares of Tenax Therapeutics, Inc. (NASDAQ:TENX - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the six research firms that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, four have assigned a buy...

Tenax Therapeutics (NASDAQ:TENX) Stock Price Passes Above Two Hundred Day Moving Average   - Should You Sell?

Tenax Therapeutics (NASDAQ:TENX) Shares Pass Above 200-Day Moving Average - What's Next...

Tenax Therapeutics, Inc. (NASDAQ:TENX) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Tenax Therapeutics, Inc. (NASDAQ:TENX - Get Free Report) has earned a consensus rating of "Moderate Buy" from the six ratings firms that are covering the firm, Marketbeat.com reports. One equities...

Tenax Therapeutics (NASDAQ:TENX) Stock Price Crosses Above 200-Day Moving Average - What's Next?

Tenax Therapeutics (NASDAQ:TENX) Stock Price Crosses Above 200-Day Moving Average - What's Next...

Tenax Therapeutics (NASDAQ:TENX) Stock Price Passes Above Two Hundred Day Moving Average   - What's Next?

Tenax Therapeutics (NASDAQ:TENX) Stock Price Crosses Above Two Hundred Day Moving Average - Should You Sell...

Cantor Fitzgerald Initiates Coverage on Tenax Therapeutics (NASDAQ:TENX)

Cantor Fitzgerald began coverage on shares of Tenax Therapeutics in a research report on Tuesday. They set an "overweight" rating and a $35.00 target price on the stock...

Boothbay Fund Management LLC Purchases Shares of 352,206 Tenax Therapeutics, Inc. $TENX

Boothbay Fund Management LLC acquired a new position in shares of Tenax Therapeutics, Inc. (NASDAQ:TENX - Free Report) in the third quarter, according to its most recent Form 13F filing with the...

Tenax Therapeutics (TENX) Expected to Announce Quarterly Earnings on Tuesday

Tenax Therapeutics (NASDAQ:TENX) will be releasing its Q4 2025 earnings before the market opens on Tuesday, March 24. (View Earnings Report at...

Guggenheim Issues Positive Forecast for Tenax Therapeutics (NASDAQ:TENX) Stock Price

Guggenheim raised their price target on shares of Tenax Therapeutics from $25.00 to $34.00 and gave the stock a "buy" rating in a report on Monday...

What is Lifesci Capital's Forecast for TENX Q1 Earnings?

Tenax Therapeutics, Inc. (NASDAQ:TENX - Free Report) - Equities researchers at Lifesci Capital issued their Q1 2026 earnings estimates for Tenax Therapeutics in a report released on Thursday, March...

Tenax Therapeutics, Inc. is a pharmaceutical company engaged in the development and commercialization of products for cardiovascular and pulmonary diseases. The company was founded on May 26, 1967 and is headquartered in Chapel Hill, NC.

TENXTenax Therapeutics Inc

Fundamentals

Feed

News

Sentiment

Fundamentals

Info

Latest TENX News